PMID- 38476896 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240314 IS - 1792-1015 (Electronic) IS - 1792-0981 (Print) IS - 1792-0981 (Linking) VI - 27 IP - 4 DP - 2024 Apr TI - Antibiotic administration aggravates asthma by disrupting gut microbiota and the intestinal mucosal barrier in an asthma mouse model. PG - 157 LID - 10.3892/etm.2024.12445 [doi] LID - 157 AB - In humans, gut microbiota can determine the health status. The regulatory mechanisms of the gut microbiota in asthma must be elucidated. Although antibiotics (ABXs) can clear infections, they markedly alter the composition and abundance of gut microbiota. The present study used ABX-treated mice to examine the time-dependent effects of ABX administration on the gut microbiota and intestinal mucosal barrier. The mouse asthma model was established using ovalbumin (OVA) and gavaged with an ABX cocktail for different durations (1 or 2 weeks) and stacked sequences. The pathology of the model, model 2, OVA-ABX, OVA-ABX 2, ABX-OVA and ABX-OVA was severe when compared with the control group as evidenced by the following results: i) significantly increased pulmonary and colonic inflammatory cell infiltration; ii) enhanced pause values and iii) OVA-induced immunoglobulin E (IgE) and TGF-beta expression levels, and significantly downregulated Tight Junction Protein 1 (TJP1), claudin 1 and Occludin expression levels. Furthermore, the intestinal bacterial load in the OVA-ABX and OVA-ABX 2 groups was significantly lower than that in the ABX-OVA and ABX-OVA 2 groups, respectively. The predominant taxa were as follows: phyla, Firmicutes and Proteobacteria, genera, Escherichia-Shigella, Lactobacillus and Lachnospira. The abundances of Lachnospira and Escherichia-Shigella were correlated with the expression of OVA-induced IgE and TJPs. These findings indicated that ABX administration, which modifies microbiome diversity and bacterial abundance, can disrupt colonic integrity, downregulate TJ proteins, damage the intestinal barrier, enhance enterocyte permeability, and promote the release of inflammatory factors, adversely affecting asthma alleviation and long-term repair. CI - Copyright: (c) 2024 Xu et al. FAU - Xu, Cheng-Ling AU - Xu CL AD - College of Basic Medical Sciences, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China. FAU - Wang, Cui AU - Wang C AD - College of Basic Medical Sciences, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China. FAU - Li, Gao-Bin AU - Li GB AD - College of Basic Medical Sciences, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China. FAU - Zhao, Tong AU - Zhao T AD - College of Basic Medical Sciences, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China. FAU - Zhou, Rui-Ling AU - Zhou RL AD - Department of Dermatology, First Affiliated Hospital, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650504, P.R. China. FAU - Chen, Jing AU - Chen J AD - College of Basic Medical Sciences, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China. LA - eng PT - Journal Article DEP - 20240221 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC10928978 OTO - NOTNLM OT - asthma OT - inflammation OT - intestinal flora OT - tight junction proteins COIS- The authors declare that they have no competing interests. EDAT- 2024/03/13 06:46 MHDA- 2024/03/13 06:47 PMCR- 2024/02/21 CRDT- 2024/03/13 04:00 PHST- 2023/02/23 00:00 [received] PHST- 2024/01/29 00:00 [accepted] PHST- 2024/03/13 06:47 [medline] PHST- 2024/03/13 06:46 [pubmed] PHST- 2024/03/13 04:00 [entrez] PHST- 2024/02/21 00:00 [pmc-release] AID - ETM-27-4-12445 [pii] AID - 10.3892/etm.2024.12445 [doi] PST - epublish SO - Exp Ther Med. 2024 Feb 21;27(4):157. doi: 10.3892/etm.2024.12445. eCollection 2024 Apr.